Compare the 7 manufacturers holding an active US Drug Master File for Glatiramer API, with DMF numbers and filing years from the FDA's quarterly DMF list.
Directory listing last reviewed October 2026.
7 manufacturers hold an active Type II Drug Master File for GlatiramerAPI, taken from the FDA's quarterly DMF list; 4 of them are listed in this directory. A DMF lets a drug applicant reference the maker's manufacturing data. It is not an FDA approval. Check each manufacturer against the FDA import alert lists before ordering.
| Manufacturer | Location | US DMF | Filed |
|---|---|---|---|
| Dr. Reddy's Laboratories | India | 25855 | 2012 |
| Hybio Pharmaceutical | China | 28989 | 2014 |
| Auro Peptides | India (Hyderabad) | 35493 | 2020 |
| Alembic Pharmaceuticals | India (Vadodara) | 44655 | 2026 |
Not yet listed in this directory, so we have not reviewed them. Names as printed in the FDA DMF list.
| DMF holder | US DMF | Filed |
|---|---|---|
| Ambio Inc | 26489 | 2012 |
| Amneal Pharmaceuticals LLC | 27723 | 2013 |
| Gland Pharma Ltd | 33092 | 2018 |
Request API quotes from several manufacturers at once. Hold a Glatiramer DMF and not listed? Add your company.